Literature DB >> 29223504

Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?

Manon Boivin1, Rob Willemsen2, Renate K Hukema2, Chantal Sellier3.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease caused by an expansion of 55-200 CGG repeats located in the FMR1 gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain atrophy, neuronal cell loss and presence of ubiquitin-positive intranuclear inclusions in both neurons and astrocytes. At the molecular level, FXTAS is characterized by increased expression of FMR1 sense and antisense RNA containing expanded CGG or GGC repeats, respectively. Here, we discuss the putative molecular mechanisms underlying FXTAS and notably recent reports that expanded CGG and GGC repeats may be pathogenic through RAN translation into toxic proteins.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  FXTAS; Microsatellite expansion; RAN translation; RNA gain-of-function

Mesh:

Substances:

Year:  2017        PMID: 29223504     DOI: 10.1016/j.ejmg.2017.11.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

Review 1.  Fragile X syndrome and associated disorders: Clinical aspects and pathology.

Authors:  Maria Jimena Salcedo-Arellano; Brett Dufour; Yingratana McLennan; Veronica Martinez-Cerdeno; Randi Hagerman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 7.046

2.  Quantitative Evaluation of Toxic Polyglycine Biosynthesis and Aggregation in Cell Models Expressing Expanded CGG Repeats.

Authors:  Magdalena Derbis; Patryk Konieczny; Agnieszka Walczak; Michal Sekrecki; Krzysztof Sobczak
Journal:  Front Genet       Date:  2018-06-19       Impact factor: 4.599

Review 3.  RNA toxicity in non-coding repeat expansion disorders.

Authors:  Bart Swinnen; Wim Robberecht; Ludo Van Den Bosch
Journal:  EMBO J       Date:  2019-11-13       Impact factor: 11.598

4.  Differential Progression of Motor Dysfunction Between Male and Female Fragile X Premutation Carriers Reveals Novel Aspects of Sex-Specific Neural Involvement.

Authors:  Danuta Z Loesch; Flora Tassone; Anna Atkinson; Paige Stimpson; Nicholas Trost; Dean L Pountney; Elsdon Storey
Journal:  Front Mol Biosci       Date:  2021-01-12

5.  Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms.

Authors:  Anke A Dijkstra; Saif N Haify; Niek A Verwey; Niels D Prins; Esmay C van der Toorn; Annemieke J M Rozemuller; Marianna Bugiani; Wilfred F A den Dunnen; Peter K Todd; Nicolas Charlet-Berguerand; Rob Willemsen; Renate K Hukema; Jeroen J M Hoozemans
Journal:  Brain Commun       Date:  2021-01-27

Review 6.  Trinucleotide CGG Repeat Diseases: An Expanding Field of Polyglycine Proteins?

Authors:  Manon Boivin; Nicolas Charlet-Berguerand
Journal:  Front Genet       Date:  2022-02-28       Impact factor: 4.599

7.  Relationships between motor scores and cognitive functioning in FMR1 female premutation X carriers indicate early involvement of cerebello-cerebral pathways.

Authors:  Elsdon Storey; Minh Q Bui; Paige Stimpson; Flora Tassone; Anna Atkinson; Danuta Z Loesch
Journal:  Cerebellum Ataxias       Date:  2021-06-11

8.  The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers.

Authors:  Danuta Z Loesch; Nicholas Trost; Minh Q Bui; Eleanor Hammersley; Sui T Lay; Sarah J Annesley; Oana Sanislav; Claire Y Allan; Flora Tassone; Zhi-Ping Chen; Kevin R W Ngoei; Bruce E Kemp; David Francis; Paul R Fisher; Elsdon Storey
Journal:  Front Genet       Date:  2018-11-12       Impact factor: 4.599

Review 9.  C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?

Authors:  Elke Braems; Bart Swinnen; Ludo Van Den Bosch
Journal:  Acta Neuropathol       Date:  2020-09-02       Impact factor: 17.088

10.  Therapeutic Development for CGG Repeat Expansion-Associated Neurodegeneration.

Authors:  Keqin Xu; Yujing Li; Emily G Allen; Peng Jin
Journal:  Front Cell Neurosci       Date:  2021-05-12       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.